European Biotech Acquisition Corp.
European Biotech Acquisition Corp. (EBAC) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
EBAC · net income · updated Jun 9, 2026
Core profitability metrics
EBAC · net income · margin · TTM · CAGRNet income was $3.5M for FY2022 (fiscal year ending 2022-12-31), up 136.9% year-over-year. Net profit margin was —. Based on available data, European Biotech Acquisition Corp. has been profitable since at least 2021.
Annual net income history
▸ FMP /income-statement · Annual · EBAC net income history · EBAC profit margin
Annual net income data
Net income vs peers (Financial Services)
About Net Income & Methodology
European Biotech Acquisition Corp. (EBAC) reported net income of $3.5M for FY2022 (fiscal year ending 2022-12-31), up 136.9% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Based on available data, European Biotech Acquisition Corp. has been profitable since at least 2021. Net income reached a peak of $3.5M in FY2022. Data available for 2 fiscal years.
European Biotech Acquisition Corp.'s net profit margin was — for FY2022, based on the latest annual results.
Investors sometimes search for "European Biotech Acquisition Corp. net worth" — the company's market capitalization is a separate figure from EBAC net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
EBAC net income · 5 questionsEuropean Biotech Acquisition Corp. is profitable. The company reported net income of $3.5M for FY2022, a net profit margin of —. Net income was up 136.9% year-over-year. Based on available data, European Biotech Acquisition Corp. has been profitable since at least 2021.
▸ Source: FMP /income-statement · GAAP · European Biotech Acquisition Corp. · European Biotech Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026